A
Aytu BioPharma, Inc. (AYTU)
NCM – Real Time Price. Currency in USD
2.30
-0.14 (-5.74%)
At close: May 12, 2026, 4:00 PM EDT
2.30
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.30
-0.14 (-5.74%)
At close: May 12, 2026, 4:00 PM EDT
2.30
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
| Name | Position |
|---|---|
| Dr. Gerwin Westfield Ph.D. | Senior Vice President of Scientific Affairs |
| Mr. Greg Pyszczymuka | Chief Commercial Officer |
| Mr. Jarrett T. Disbrow Ph.D. | Chief Business Officer |
| Mr. Joshua R. Disbrow | CEO & Director |
| Mr. Ryan J. Selhorn CPA | CFO, Corporate Secretary & Treasurer |
| Ms. Margaret Cabano | Vice President of Operations |
| Date | Type | Document |
|---|---|---|
| 2026-04-02 | 8-K | aytu20260327_8k.htm |
| 2026-02-03 | 8-K | aytu20251124_8k.htm |
| 2026-02-03 | 10-Q | aytu20251231_10q.htm |
| 2026-01-20 | 8-K | aytu20260118_8k.htm |
| 2025-12-10 | 8-K | aytu20251204_8k.htm |
| 2025-11-13 | 8-K | aytu20250924_8k.htm |
| 2025-11-13 | 10-Q | aytu20250930_10q.htm |
| 2025-10-24 | DEF 14A | aytu20250915_def14a.htm |
| 2025-09-23 | 8-K | aytu20250514_8k.htm |
| 2025-09-23 | 10-K | aytu20250630c_10k.htm |